{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:58:43Z","timestamp":1792511923000,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpn.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:24:34Z","timestamp":1752625474000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Association of 5-HT, ET-1, PTX-3, and inflammatory markers with clinical parameters in pediatric migraine patients with patent foramen ovale"],"prefix":"10.1016","volume":"58","author":[{"given":"Yali","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpn.2025.07.003_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s10194-025-02004-4","article-title":"Effects of acute sleep deprivation on the brain function of individuals with migraine: a resting-state functional magnetic resonance imaging study","volume":"26","author":"Wang","year":"2025","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.ejpn.2025.07.003_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s10194-025-02000-8","article-title":"Association between proton pump inhibitor use and migraine: a systematic review and meta-analysis","volume":"26","author":"Satapathy","year":"2025","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.ejpn.2025.07.003_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s10194-025-01993-6","article-title":"Differential fMRI neural synchrony associated with migraine during naturalistic stimuli with negative emotional valence","volume":"26","author":"Klamer","year":"2025","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.ejpn.2025.07.003_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1460403","article-title":"The serum proteomic profile in patients with migraine","volume":"18","author":"Han","year":"2025","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.ejpn.2025.07.003_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5152\/pcp.2024.23810","article-title":"Advances in the study of the correlation between patent foramen ovale and migraine","volume":"34","author":"Zuo","year":"2024","journal-title":"Psychiatry. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejpn.2025.07.003_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241271033","article-title":"Efficacy and safety of patent foramen ovale closure for mitigating migraine: a systematic review and meta-analysis of randomized trials and observational studies","volume":"17","author":"Silalahi","year":"2024","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1","key":"10.1016\/j.ejpn.2025.07.003_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12883-024-03615-1","article-title":"Calcitonin gene-related peptide: a possible biomarker in migraine patients with patent foramen ovale","volume":"24","author":"Li","year":"2024","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.ejpn.2025.07.003_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32105","article-title":"Association of in situ thrombus within the patent foramen ovale and patients with migraine: a prospective cohort study","volume":"10","author":"Hou","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib9","first-page":"497","article-title":"Migraine headache and patent foramen ovale: observational studies, the randomized clinical trials, and the GORE RELIEF clinical study","volume":"42","author":"Sommer","year":"2024","journal-title":"Cardiol. Clin."},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s11682-024-00868-9","article-title":"Association between patent foramen ovale and migraine: evidence from a resting-state fMRI study","volume":"18","author":"Tang","year":"2024","journal-title":"Brain Imag. Behav."},{"issue":"7","key":"10.1016\/j.ejpn.2025.07.003_bib11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-024-02760-8","article-title":"Headache patterns in patent foramen ovale patients: beyond migraine with aura","volume":"131","author":"Badea","year":"2024","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.ejpn.2025.07.003_bib12","article-title":"A new syndrome of patent foramen ovale inducing vasospastic angina and migraine","volume":"28","author":"Ravi","year":"2023","journal-title":"JACC Case Rep."},{"issue":"2","key":"10.1016\/j.ejpn.2025.07.003_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/echo.15770","article-title":"Comparison of echocardiographic and clinical characteristics in embolic stroke and migraine patients with patent foramen ovale","volume":"41","author":"Polat","year":"2024","journal-title":"Echocardiography"},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib14","first-page":"111","article-title":"Preliminary exploration of metabolomics mechanisms in patients with patent foramen ovale and migraine","volume":"38","author":"Tuerxun","year":"2024","journal-title":"J. Oral. Facial Pain Headache."},{"issue":"1","key":"10.1016\/j.ejpn.2025.07.003_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s40001-025-02423-8","article-title":"Association of atrial cardiopathy and residual shunt after patent foramen ovale closure in patients experiencing migraine","volume":"30","author":"Gao","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"11","key":"10.1016\/j.ejpn.2025.07.003_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/echo.70018","article-title":"Anatomical significance of the patent foramen ovale by real-time 3D TEE in cryptogenic stroke and migraine","volume":"41","author":"Wang","year":"2024","journal-title":"Echocardiography"},{"issue":"6","key":"10.1016\/j.ejpn.2025.07.003_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9972","article-title":"Metabolomic analysis of patients with patent foramen ovale and migraine using liquid chromatography-mass spectrometry technology","volume":"39","author":"Tuerxun","year":"2025","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ejpn.2025.07.003_bib18","article-title":"Study on the correlation between patent foramen ovale and migraine based on Meta analysis","author":"Zhou","year":"2024","journal-title":"Altern. Ther. Health Med."},{"issue":"39","key":"10.1016\/j.ejpn.2025.07.003_bib19","article-title":"Multimodal ultrasound imaging for patent foramen ovale and pulmonary arteriovenous malformation in patients with cryptogenic stroke or migraine: a prospective diagnostic study","volume":"103","author":"Xu","year":"2024","journal-title":"Medicine (Baltim.)"},{"issue":"8","key":"10.1016\/j.ejpn.2025.07.003_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41582-023-00842-x","article-title":"The 5-HT(1F) receptor as the target of ditans in migraine - from bench to bedside","volume":"19","author":"Mitsikostas","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejpn.2025.07.003_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6663591","article-title":"The effect and safety of 5-HT(1F) receptor agonist lasmiditan on migraine: a systematic review and meta-analysis","volume":"2021","author":"Gu","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.ejpn.2025.07.003_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bph.15710","article-title":"5-hydroxytryptamine in migraine: the puzzling role of ionotropic 5-HT(3) receptor in the context of established therapeutic effect of metabotropic 5-HT(1) subtypes","volume":"179","author":"Giniatullin","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejpn.2025.07.003_bib23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41422-021-00527-4","article-title":"Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT(1F)-G protein complex","volume":"31","author":"Huang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ejpn.2025.07.003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113782","article-title":"Design, synthesis and biological evaluation of pyridinylmethylenepiperidine derivatives as potent 5-HT(1F) receptor agonists for migraine therapy","volume":"225","author":"Jin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejpn.2025.07.003_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/01616412.2025.2456708","article-title":"Migraine and ergot use increase plasma pentraxin 3 levels: an Egyptian study","volume":"47","author":"Fahmy","year":"2025","journal-title":"Neurol. Res."},{"issue":"6","key":"10.1016\/j.ejpn.2025.07.003_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/10799893.2022.2097264","article-title":"Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack?","volume":"42","author":"Vural","year":"2022","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"3","key":"10.1016\/j.ejpn.2025.07.003_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030849","article-title":"Pentraxin 3 (PTX3): a molecular marker of endothelial dysfunction in chronic migraine","volume":"9","author":"Dominguez-Vivero","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ejpn.2025.07.003_bib28","first-page":"1","article-title":"The effect of nano-curcumin supplementation on pentraxin 3 gene expression and serum level in migraine patients","volume":"9","author":"Djalali","year":"2020","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.ejpn.2025.07.003_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1177\/0333102415598757","article-title":"Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics","volume":"36","author":"Ceylan","year":"2016","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.ejpn.2025.07.003_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajem.2019.04.004","article-title":"Pentraxin 3 level in acute migraine attack with aura: patient management in the emergency department","volume":"38","author":"Gokdemir","year":"2020","journal-title":"Am. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jacc.2005.05.029","article-title":"Patent foramen ovale\/atrial septal defect closure and migraine: searching the rationale for the procedure","volume":"46","author":"Gupta","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ejpn.2025.07.003_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.wco.0000169749.52406.74","article-title":"Patent foramen ovale: paradoxical connection to migraine and stroke","volume":"18","author":"Diener","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ejpn.2025.07.003_bib33","article-title":"Association of migraine with patent foramen ovale closure: a systematic review and meta-analysis","volume":"39","author":"Wang","year":"2022","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s10194-005-0223-9","article-title":"Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype","volume":"6","author":"Dalla Volta","year":"2005","journal-title":"J. Headache Pain"},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib35","doi-asserted-by":"crossref","first-page":"922 e921","DOI":"10.1016\/j.ahj.2005.09.019","article-title":"Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting","volume":"151","author":"Giardini","year":"2006","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.ejpn.2025.07.003_bib36","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1468-2982.2006.01156.x","article-title":"Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial doppler study","volume":"26","author":"Carod-Artal","year":"2006","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.ejpn.2025.07.003_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10194-005-0154-5","article-title":"High prevalence of patent foramen ovale in migraine with aura","volume":"6","author":"Ferrarini","year":"2005","journal-title":"J. Headache Pain"},{"issue":"3","key":"10.1016\/j.ejpn.2025.07.003_bib38","first-page":"362","article-title":"Does patent foramen ovale promote cryptogenic stroke and migraine headache?","volume":"32","author":"Tobis","year":"2005","journal-title":"Tex. Heart Inst. J."},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib39","first-page":"625","article-title":"Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke","volume":"67","author":"Giardini","year":"2006","journal-title":"Cathet. Cardiovasc. Interv."},{"issue":"6","key":"10.1016\/j.ejpn.2025.07.003_bib40","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/0003-4819-144-6-200603210-00028","article-title":"Primary patent foramen ovale closure to relieve severe migraine","volume":"144","author":"Rigatelli","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ncpcardio0513","article-title":"Patent foramen ovale closure to treat migraine headache","volume":"3","author":"Orr","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.ejpn.2025.07.003_bib42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1526-4610.2006.00375.x","article-title":"Patent foramen ovale and migraine: why the flap?","volume":"46","author":"Shapiro","year":"2006","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1526-4610.2006.00433.x","article-title":"Patent foramen ovale and migraine--bringing closure to the subject","volume":"46","author":"Schwedt","year":"2006","journal-title":"Headache"},{"issue":"5-6","key":"10.1016\/j.ejpn.2025.07.003_bib44","first-page":"362","article-title":"[Patent foramen ovale and migraine, a fortuitus association or a causal relationship?]","volume":"61","author":"Schoenen","year":"2006","journal-title":"Rev. Med. Liege"},{"issue":"1-2","key":"10.1016\/j.ejpn.2025.07.003_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jns.2015.01.015","article-title":"Association of the long pentraxin PTX3 gene polymorphism (rs3816527) with migraine in an Iranian population","volume":"349","author":"Zandifar","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.ejpn.2025.07.003_bib46","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1161\/01.STR.0000248217.23136.9e","article-title":"Migraine relief after patent foramen ovale closure: should vascular risk factor control be achieved first?","volume":"37","author":"Di Legge","year":"2006","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ejpn.2025.07.003_bib47","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijcard.2006.09.002","article-title":"Is patent foramen ovale the culprit in women with migraine and cardiovascular disease?","volume":"113","author":"Cheng","year":"2006","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ejpn.2025.07.003_bib48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/03331024221075616","article-title":"Interictal plasma endothelin-1 levels do not change in individuals with episodic and chronic migraine","volume":"42","author":"Kim","year":"2022","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ejpn.2025.07.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.114992","article-title":"Classical prescription dachuanxiong formula delays nitroglycerin-induced pain response in migraine mice through reducing endothelin-1 level and regulating fatty acid biosynthesis","volume":"288","author":"Vong","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.ejpn.2025.07.003_bib50","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/head.13753","article-title":"Intravenous Endothelin-1 infusion does not induce aura or headache in migraine patients with aura","volume":"60","author":"Hougaard","year":"2020","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.ejpn.2025.07.003_bib51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14715\/cmb\/2020.66.6.7","article-title":"Tuling wendan decoction combined with flunarizine in the treatment of migraine patients and the effect of intervention on serum cyclooxygenase-2, endothelin-1 and nitric oxide","volume":"66","author":"Xie","year":"2020","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"issue":"2","key":"10.1016\/j.ejpn.2025.07.003_bib52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00001756-199902050-00039","article-title":"Simultaneous monitoring of endothelin-1 and vasopressin plasma levels in migraine","volume":"10","author":"Hasselblatt","year":"1999","journal-title":"Neuroreport"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825001047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379825001047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:18:24Z","timestamp":1761963504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379825001047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"alternative-id":["S1090379825001047"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.07.003","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of 5-HT, ET-1, PTX-3, and inflammatory markers with clinical parameters in pediatric migraine patients with patent foramen ovale","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}